BioCatalystWatch
TYRAWorkspace / TYRA / OverviewCompany library
Tyra Biosciences, Inc. logo

Tyra Biosciences, Inc.

Tyra Biosciences, Inc. (TYRA)

Website

Price
Market cap
Next catalystExpected 2026Dabogratinib — SURF302, Phase 2 ablative IR NMIBC · Conference presentationCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

Dabogratinib

FGFR3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Dabogratinib

FGFR3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Dabogratinib

FGFR3

PreINDP1P2P3FilingApproved
Upcoming / outlook

Dabogratinib

FGFR3

PreINDP1P2FilingApproved
Upcoming / outlook

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

Dabogratinib

FGFR3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Dabogratinib

FGFR3

PreINDP1P2P3FilingApproved
Upcoming / outlook

Dabogratinib

FGFR3

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Dabogratinib

FGFR3

PreINDP1P2FilingApproved
Upcoming / outlook

Other pipelines

TYRA-430

FGFR4 × FGFR3

PreINDP1P2P3FilingApproved
TYRA-200

PreINDP1P2P3FilingApproved

History / paused

Dabogratinib

FGFR3

PreINDP1P2P3FilingApproved

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

TYRA PR & News

PR & News

TYRA SEC archive